3D Precision Therapy
Successfully Treats Various Chronic
Prostate Diseases

3D Prostate Precise Therapy

Chlamydia and Mycoplasma Infection

Chlamydia and mycoplasma is the most common pathogens of non bacterial prostatitis, epididymitis ,and non gonococcal urethritis.

Chlamydia and mycoplasma are common sexually transmitted disease (STD) caused by the chlamydia trachomatis and ureaplasma urealyticum . Chlamydia and mycoplasma can damage the reproductive system in both men and women. Although symptoms of chlamydia and mycoplasma can be mild or absent, serious complications causing irreversible damage, including infertility, can occur before an infected person realizes the problem.
Chlamydia and mycoplasma can be transmitted during vaginal, anal, and oral sex. They can be passed from an infected mother to her baby during vaginal childbirth. Any sexually active person can be infected with chlamydia and mycoplasma. And, the greater the number of sex partners a person has (or had), the greater the risk of infection.

Most unfortunate is the ability of chlamydia and mycoplasma to hide itself deep inside the genitourinary tract making it very difficult to detect by urethral swabbing and urine analysis; two commonly used sample collection methods for chlamydia and mycoplasma testing in clinical practice. Thus, many urologists and STD doctors are unable to identify chlamydia and mycoplasma as a causative pathogen. As a result, they often make general diagnosis, such as, non-specific urethritis, prostatitis, and/or pelvic inflammatory disease (PID), etc. And, they frequently prescribe a variety of ineffective broad-spectrum antibiotics making the patient condition more complicated; weakening the immune system, causing antibiotic resistance, failing to address causative pathogens, and allowing the infection to spread, etc.

Chlamydia and Mycoplasma Pathogencity

Most unChlamydia and mycoplasma are prokaryot intracellular parasite; a microorganism, which are different from a common bacteria or virus. The prokaryotes are a group of organisms that lack a cell nucleus or any other membrane-bound organelles. Chlamydia and mycoplasma , unlike other bacteria, differs in the way it synthesizes energy. Bacteria usually synthesize energy by Adenosine Triphosphate (ATP); a general way of synthesizing energy by living cells. However, Chlamydia and mycoplasma synthesizes energy directly from the infected host cells; it suppresses the metabolism and dissolves the cells. Overtime, the cells are destroyed, the infected person immune system is weakened, and the infection spreads.

Chlamydia and mycoplasma are known as the silent disease because the majority of infected people have no symptoms during the early stages of infection. When symptoms are noticed, complications have usually occurred. These complications include: urethritis, prostatitis, epididymitis, and infertility, etc. (in men); and pelvic inflammatory disease (PID), ectopic pregnancy, and infertility, etc. (in women). Chlamydia and mycoplasma can also cause blindness, junctivitis, arthritis, pneumonia, bronchitis, and lymphogranuloma venereum (LGV), etc.

Chronic genitourinary tract chlamydia and mycoplasma infections often result in complications. Prostate tubes, spermatic ducts, epididymal ducts, ejaculatory ducts, and ovarian ducts become blocked. Overtime scarring, calcification, and irreversible damage occur. Once this happens, antibiotics cannot reach the blocked and scared areas making chlamydia and mycoplasma very difficult to cure.

Fortunate is the ability of chlamydia and mycoplasma to hide itself deep inside the genitourinary tract making it very difficult to detect by urethral swabbing and urine analysis; two commonly used sample collection methods for chlamydia and mycoplasma testing in clinical practice. Thus, many urologists and STD doctors are unable to identify chlamydia and mycoplasma as a causative pathogen. As a result, they often make general diagnosis, such as, non-specific urethritis, prostatitis, and/or pelvic inflammatory disease (PID), etc. And, they frequently prescribe a variety of ineffective broad-spectrum antibiotics making the patient condition more complicated; weakening the immune system, causing antibiotic resistance, failing to address causative pathogens, and allowing the infection to spread, etc.

Chlamydia and mycoplasma Symptoms

At the early stage of chlamydia and mycoplasma infection, most of patients have no symptoms. Symptoms may appear 1 to 3 weeks and months later when complications emerge.
For men, genitourinary chlamydia and mycoplasma infections usually start in the anterior urethra, then move to the posterior urethra, prostate, seminal vesicles, spermatic ducts, and epididymis.

The complications include:

1) At the early stage of chlamydia and mycoplasma infection, some patients may have urethritis within 1 to 4 weeks. Common symptoms include: itching, pain, and burning during urination; pus, watery, and milky discharge from the penis; and frequent urination.

2) In the chronic stage of chlamydia and mycoplasma infection, complications of the prostate usually occur. Common symptoms include: pain, tension, and discomfort in perineal area; pain around the anus; sexual function disorder; pain in the prostate; enlarged and inflamed prostate; weak urine flow, and/or frequent night urination; epididymitis; pain or tenderness in testicles; thickening of the spermatic ducts; poor semen quality; blockage and calcification; and infertility, etc.

3) Other chlamydia and mycoplasma symptoms include: seminal vesiculitis; change in semen color, yellowish and bloody semen, decrease in semen volume, and pain during and after ejaculation; and pain or discomfort in the butt or thighs. Patients who engage in anal sex may have rectitis. Patients who engage in oral sex may have pharyngolaryngitis and pneumoniae. Few patients may develop Reiter Syndrome; arthritis, conjunctivitis, and urethritis at the same time.

For women with genitourinary chlamydia and mycoplasma infections

The most common place of chlamydia and mycoplasma infection is the cervix causing cervicitis; inflammation of the uterine cervix. Common symptoms include: painful intercourse, abnormal vaginal discharge (a yellowish discharge from the cervix that may have a strong odor), cervix erosion, vaginal bleeding after intercourse, and cervix congestion, etc. Abnormal vaginal discharge may affect the urethra causing urethritis; pain or burning while urinating, frequent urination, and the urge to urinate more than usual.
The infection in the cervix will spread to the ovarian ducts and other organs causing endometritis, salpingitis, and pelvic inflammatory disease (PID), etc. Common symptoms include: abdominal pain, pain in the lower back, low fever, irregular menstruation, and bleeding between menstrual periods, spontaneous abortion, extrauterine pregnancy, blocked fallopian tubes, and infertility, etc.

Chlamydia and Mycoplasma and Infertility

Research indicates that among patients who have infertility, about 50% to 60% of them are positive for chlamydia and/or mycoplasma. We believe the infection rate is higher. We find that most of our patients have active pathogen infections (see laboratory testing). chlamydia and mycoplasma are the major cause of ectopic pregnancy and infertility in Western countries. Our research indicates most patients suffering from infertility because of active causative pathogens.

Chlamydia and mycoplasma are common sexually transmitted pathogens found in genitourinary infections. They can cause prostatitis and epididymitis in males, and cervicitis and pelvic inflammatory disease PID in females. These, infectious pathogens alter and damage the inner reproductive systems. They cause infertility, miscarriage, and/or the birth of unhealthy children, etc.

Chlamydia and mycoplasma Lab Testing

Currently, in clinical practice there are several standard chlamydia and mycoplasma test methods available to check for chlamydia and mycoplasma genitourinary infection. However, most of these tests often give inaccurate results. One such widely used chlamydia and mycoplasma test is the rapid screening (colloidal gold) method in which urine and urethral swabs are used in sample collection. We found this method gives inaccurate chlamydia and mycoplasma test results.

Since chlamydia and mycoplasma lives inside epithelia cells, it is difficult to obtain accurate chlamydia and mycoplasma test results because these methods require tissue samples to be collected from the infected areas. In the chronic chlamydia and mycoplasma infection stage, chlamydia and mycoplasma tends to hide inside tissues located deep within the genitourinary system. The locations of the chlamydia and mycoplasma infection make it difficult to collect qualified samples. Thus, it is hard to obtain accurate chlamydia and mycoplasma test results using standard chlamydia and mycoplasma test methods.

In our clinical research, we have found the most accurate chlamydia and mycoplasma test methods for genitourinary chlamydia and mycoplasma infection are the following:

1) For acute chlamydia and mycoplasma urinary or cervix infection with inflammatory discharge: urethral swab and/or cervix swab, and swab of the infected areas for the antigen of chlamydia and mycoplasma using the PCR test.

2) For chronic chlamydia and mycoplasma infection and complications: blood serum for the IgM antibody of chlamydia using the ELISA test,semen and inflammatory secretion culture for mycoplasma.Male patients who have pain in the testicles, and female patients who have pain in the pelvic area, should have these tests performed. Patients should go to an advanced laboratory to have this chlamydia and mycoplasma test done.

Treatment for Chlamydia and Mycoplasma

Currently, in cliniConventional medical knowledge suggests that chlamydia and mycoplasma can easily be cured. Treatment guidelines for sexually transmitted disease (STD) recommend taking oral antibiotics for one week or less to treat chlamydia and mycoplasma infections. We do not agree.

For a patient who has an acute chlamydia and mycoplasma urinary tract infection, taking oral antibiotics for short periods (less than two weeks) will most likely only control the reproduction of chlamydia and mycoplasma and suppress the symptoms. This type of treatment will usually not kill the infection. Patients often relapse, symptoms reemerge, and complications occur. For acute chlamydia and mycoplasma genitourinary tract infections, we recommend taking oral antibiotics for at least two weeks. Heavy dosages and/or broad-spectrum antibiotics should be avoided. These will cause bacteria imbalance, antibiotic resistance, and other side effects. We recommend taking azithromycin and doxycycline, and to avoid alcohol, and sexual activity during treatment.

For chronic chlamydia and mycoplasma genitourinary tract infections and the resulting complications, oral antibiotics will not kill the infection because the medicine cannot penetrate the infected and blocked areas in high enough concentrations. The infected areas are often located deep inside the genitourinary tract. For chronic patients who relapse with oral antibiotic treatments, we recommend our 3D Precise Treatment. We have successfully treated many patients, both male and female, with deep genitourinary tract chlamydia and mycoplasma infections using our 3D Precise Treatment.cal practice there are several standard chlamydia and mycoplasma test methods available to check for chlamydia and mycoplasma genitourinary infection. However, most of these tests often give inaccurate results. One such widely used chlamydia and mycoplasma test is the rapid screening (colloidal gold) method in which urine and urethral swabs are used in sample collection. We found this method gives inaccurate chlamydia and mycoplasma test results.

Since chlamydia and mycoplasma lives inside epithelia cells, it is difficult to obtain accurate chlamydia and mycoplasma test results because these methods require tissue samples to be collected from the infected areas. In the chronic chlamydia and mycoplasma infection stage, chlamydia and mycoplasma tends to hide inside tissues located deep within the genitourinary system. The locations of the chlamydia and mycoplasma infection make it difficult to collect qualified samples. Thus, it is hard to obtain accurate chlamydia and mycoplasma test results using standard chlamydia and mycoplasma test methods.

In our clinical research, we have found the most accurate chlamydia and mycoplasma test methods for genitourinary chlamydia and mycoplasma infection are the following:

95%

3D Precise Therapy is suitable for various chlamydia and mycoplasma infection.
The cure rate of 3D Unblocking Therapy is over 95%.

3D Precise Therapy Successfully Treat Various Chronic Chlamydia and Mycoplasma Infection

3D Precise Therapy is an advanced method to successfully treat various chronic chlamydia and mycoplasma infection without any side effects. Most therapeutic medicines are natural targeted extracts with no side effects and no drug resistance. Natural targeted extracts can target specific diseased areas and allow effective ingredients to accumulate in the targeted diseased areas and form a higher therapeutic concentration. 3D Precise Therapy treats the root factors of chronic chlamydia and mycoplasma infection. Once cured, the patient’s disease will not easily relapse.

3D Precise Therapy medicines include the powerful anti-inflammatory natural targeted extracts combined with the proprietary unblocking natural targeted extracts.

The powerful anti-inflammatory natural targeted extracts combined with the proprietary unblocking natural targeted extracts can destroy the biofilm pathogens and inflammatory factors, discharge toxic compounds and blocked particles, and successfully treats various chlamydia and mycoplasma infection diseases. The natural targeted extracts have no side effects and no drug resistance.

3D Precise Therapy is divided into two treatment options: 3D Precise Therapy at the clinic, and 3D Precise Therapy at home.

The treatment course and treatment options of 3D Precise Therapy will be based on your condition and doctor’s treatment plan. Generally speaking, the course of 3D Precise Therapy at the clinic is 4 weeks, and the course of 3D Precise Therapy at home is 4 months.

3D Precise Therapy is suitable for various chlamydia and mycoplasma infection. The cure rate of 3D Precise Therapy is over 95%.